Literature DB >> 2872390

Plasma inhibin levels during gonadotropin-induced ovarian hyperstimulation for IVF: a new index of follicular function?

R I McLachlan, D M Robertson, D L Healy, D M de Kretser, H G Burger.   

Abstract

Human plasma inhibin was measured by radioimmunoassay in 26 women undergoing ovarian hyperstimulation for in-vitro fertilisation. Plasma inhibin rose in parallel with oestradiol during gonadotropin therapy (r = 0.79, p less than 0.001). Peak plasma inhibin levels correlated with follicle number as determined by ultrasonography (p less than 0.001) and with the number of oocytes recovered at laparoscopy (p less than 0.05). The increase in production of human ovarian inhibin by exogenous follicle stimulating hormone (FSH) is thus consistent with its proposed role in FSH regulation. Human plasma inhibin may be useful as a circulating protein marker of granulosa-cell function and may have therapeutic implications in human ovulation-induction programmes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872390     DOI: 10.1016/s0140-6736(86)91385-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

Review 1.  Recent advances in the human physiology of inhibin secretion.

Authors:  D M de Kretser; D M Robertson; G P Risbridger
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

2.  FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs.

Authors:  Dimitris Loutradis; Eleni Patsoula; Vassilis Minas; Giorgos A Koussidis; Aristeidis Antsaklis; Stylianos Michalas; Antonis Makrigiannakis
Journal:  J Assist Reprod Genet       Date:  2006-05-19       Impact factor: 3.412

3.  Intraovarian markers of follicular and oocyte maturation.

Authors:  A Pellicer; M P Diamond; A H DeCherney; F Naftolin
Journal:  J In Vitro Fert Embryo Transf       Date:  1987-08

Review 4.  Drugs used in in vitro fertilisation procedures.

Authors:  I E Messinis
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

5.  Relative roles of follicle-stimulating hormone and luteinizing hormone in the control of inhibin secretion in normal men.

Authors:  R I McLachlan; A M Matsumoto; H G Burger; D M de Kretser; W J Bremner
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

6.  The sequential use of a luteinizing hormone-releasing hormone (LH-RH) agonist and human menopausal gonadotropins to stimulate folliculogenesis in patients with resistant ovaries.

Authors:  V Sharma; J Williams; W Collins; A Riddle; B Mason; M Whitehead
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-02

7.  Spontaneous luteinizing hormone (LH) surges are associated with more rapidly increasing estradiol (E2) and follicle stimulating hormone (FSH) in in vitro fertilization and embryo transfer.

Authors:  D Kreiner; K Droesch; J Itskovitz; H C Liu; D Navot; Z Rosenwaks
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-10

8.  The initial flare-up induced by gonadotropin releasing hormone agonist may serve as a predictor of ovarian response in the current IVF-ET treatment cycle in normogonadotropic women aged 40-48 years.

Authors:  O M Avrech; M Royburt; G Sabah; Z Zukerman; H Pinkas; S Amit; J Ovadia; B Fisch
Journal:  J Assist Reprod Genet       Date:  1996-05       Impact factor: 3.412

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.